Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

H.C. Wainwright Cell Therapy Virtual ConferenceFireside Chat recording available on Tuesday, February 28, 2023 at 7:00 am ET

Inaugural Mizuho Oncology Therapeutics SummitPanel: Developing & Commercializing Cell TherapyDate: Monday, March 13, 2023 at 8:00 am Location: Cadillac Hotel & Beach Club, Miami, FL

Oppenheimer 33rd Annual Virtual Healthcare Conference Presentation: Monday, March 13, 2023 at 1:20 pm ET

Barclays Global Healthcare ConferenceFireside Chat: Wednesday, March 15, 2023 at 2:05 pm ETLocation: Loews Miami Beach Hotel, Miami, FL

A live webcast and archived replay of the presentation and fireside chats will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer +1 857-242-6076[email protected]

You May Also Be Interested In

• Rocket Lab Satellite Platforms Built for MDA Space Successfully Reach Orbit, Supporting Globalstar Direct-to-Device Communications Services
• Best Memecoin to Buy: MemeToro Goes Open Source as DOGE and SHIB Struggle Below Key Resistance
• APIC delivers 55% EBITDA growth in the first half of 2026, reaching USD 44 million